Cautionary Note on Forward-Looking Statements and Disclaimers

This presentation includes statements that constitute “forward-looking statements” within the meaning of the U.S. federal securities laws. These statements relate to future events or to our future performance and involve significant known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in these forward-looking statements. These statements include, but are not limited to, information or assumptions about our ability to formulate, implement and gain market acceptance of our business plan and our medical device suite, the viability of our intellectual property, our financing needs and plans, and our management’s plans, goals and objectives for future operations and growth. In some cases, you can identify forward-looking statements using words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “continue,” or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve significant known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could cause actual performance or results to differ materially from those expressed in or suggested by forward-looking statements. Important factors that could cause such differences to include, but are not limited to: (i) risks and uncertainties associated with the development and implementation (ii) the risk that we may be unable to raise capital when needed; (iii) the risk that we may be unable to gain market acceptance for Stimcore,Inc.; and risks associated with maintaining or protecting the validity of patents and other intellectual property. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material or even significant respects from those projected in these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. Sales, revenue, and other economic estimates have been determined on-the-basis-of market research and comparable product analysis, but no assurances can be given that such results will be achieved, if at all. This presentation contains trademarks, trade names, and service marks of other companies, which are the property of their respective owners. We do not intend to use or display other parties’ trademarks, trade names or service marks to imply, and such use or display should not be construed to imply a relationship with, or endorsement, or sponsorship of us by, these other parties. All references herein to the “Company,” “we,” “us,” “our” and similar terminology refer to Stimcore, Inc.

Frost and Sulivan/Hidden Health Crisis Costing America Billions aasm.org, Healio OSA 1 Billion, NCBI NIN.GOV OSA SLEEP APNEA, Grandview Research.com OSA and sleep apnea, Industry/Analysis/sleep apnea device market, Market Watch.com Press Release Global Sinitus, Market Research Future.com Acute Sinitus WBAC Sinitus 2021

©2021/2022 Stimcore, Inc. ALL RIGHTS RESERVED. CONFIDENTIAL | NOT FOR REDISTRIBUTION